637 related articles for article (PubMed ID: 29598869)
21. Prescription of renin-angiotensin system inhibitors in Japan during the COVID-19 pandemic: interrupted time series study.
Miura R; Okada K
Hypertens Res; 2023 Dec; 46(12):2593-2602. PubMed ID: 37463982
[TBL] [Abstract][Full Text] [Related]
22. Three-Year Cardiovascular Outcomes of Telmisartan in Patients With Hypertension: An Electronic Health Record-Based Cohort Study.
Yum Y; Kim JH; Joo HJ; Kim YH; Kim EJ
Am J Hypertens; 2024 May; 37(6):429-437. PubMed ID: 38285627
[TBL] [Abstract][Full Text] [Related]
23. Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease.
Gregg LP; Richardson PA; Herrera MA; Akeroyd JM; Jafry SA; Gobbel GT; Wydermyer S; Arney J; Hung A; Matheny ME; Virani SS; Navaneethan SD
Am J Nephrol; 2023; 54(3-4):126-135. PubMed ID: 37231800
[TBL] [Abstract][Full Text] [Related]
24. Carotid artery intima-media thickness and the renin-angiotensin system.
Johnson CT; Brewster LP
Hosp Pract (1995); 2013 Apr; 41(2):54-61. PubMed ID: 23680737
[TBL] [Abstract][Full Text] [Related]
25. Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding.
Cohen JB; D'Agostino McGowan L; Jensen ET; Rigdon J; South AM
J Hypertens; 2021 Apr; 39(4):795-805. PubMed ID: 33186321
[TBL] [Abstract][Full Text] [Related]
26. A Rare Case of Losartan-Induced Visceral Angioedema.
Rosas S; Fowler A; Stodgill E; Deyo-Svendsen M; Phillips M
J Prim Care Community Health; 2023; 14():21501319231213744. PubMed ID: 37965705
[TBL] [Abstract][Full Text] [Related]
27. Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study.
Franchi C; Rossio R; Mandelli S; Ardoino I; Nobili A; Peyvandi F; Mannucci PM;
Intern Emerg Med; 2024 Apr; 19(3):689-696. PubMed ID: 38353881
[TBL] [Abstract][Full Text] [Related]
28. Management of hypertension in heart transplant recipients: an ongoing conundrum.
Torres JD; Krim SR
Curr Opin Cardiol; 2024 Jul; 39(4):273-278. PubMed ID: 38547158
[TBL] [Abstract][Full Text] [Related]
29. Antihypertensive agents in hemodialysis patients: a current perspective.
Inrig JK
Semin Dial; 2010; 23(3):290-7. PubMed ID: 20374548
[TBL] [Abstract][Full Text] [Related]
30. Management of Hypertension in the Asia-Pacific Region: A Structured Review.
Rahman ARA; Magno JDA; Cai J; Han M; Lee HY; Nair T; Narayan O; Panyapat J; Van Minh H; Khurana R
Am J Cardiovasc Drugs; 2024 Mar; 24(2):141-170. PubMed ID: 38332411
[TBL] [Abstract][Full Text] [Related]
31. Patient-Reported Reasons for Antihypertensive Medication Change: A Quantitative Study Using Social Media.
Micale C; Golder S; O'Connor K; Weissenbacher D; Gross R; Hennessy S; Gonzalez-Hernandez G
Drug Saf; 2024 Jan; 47(1):81-91. PubMed ID: 37995049
[TBL] [Abstract][Full Text] [Related]
32. Five-Membered Nitrogen Heterocycles Angiotensin-Converting Enzyme (ACE) Inhibitors Induced Angioedema: An Underdiagnosed Condition.
Papapostolou N; Gregoriou S; Katoulis A; Makris M
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543146
[TBL] [Abstract][Full Text] [Related]
33. New developments in the pharmacological treatment of hypertension: dead-end or a glimmer at the horizon?
Paulis L; Rajkovicova R; Simko F
Curr Hypertens Rep; 2015 Jun; 17(6):557. PubMed ID: 25893478
[TBL] [Abstract][Full Text] [Related]
34. The epigenetic legacy of renin-angiotensin system inhibition in preventing hypertension.
Nosalski R; Lemoli M
Cardiovasc Res; 2024 May; 120(7):675-677. PubMed ID: 38634882
[No Abstract] [Full Text] [Related]
35. Impact on clinical outcomes of renin-angiotensin system inhibitors against doxorubicin-related toxicity in patients with breast cancer and hypertension: A nationwide cohort study in South Korea.
Hwang HJ; Lee TG
PLoS One; 2023; 18(11):e0294649. PubMed ID: 37983233
[TBL] [Abstract][Full Text] [Related]
36. Natural angiotensin converting enzyme inhibitors: A safeguard against hypertension, respiratory distress syndrome, and chronic kidney diseases.
Khaled A; Ahmed E; Mamdouh M; Saad H; Mohamed A; Sobhy M; Piatti D; Sabry M; Saad MA; Sabry OM; Caprioli G
Phytother Res; 2023 Dec; 37(12):5464-5472. PubMed ID: 37675925
[TBL] [Abstract][Full Text] [Related]
37. ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients.
Daoud A; Ali H; Rao V; Rohan V; Soliman K
Ren Fail; 2021 Dec; 43(1):1463-1464. PubMed ID: 34704916
[No Abstract] [Full Text] [Related]
38. Losartan-Induced Angioedema with Acute Hypoxemic Respiratory Failure (Anaphylaxis): A Case Report.
Kagzi Y; Money DB; Oxner AZ; Kagzi A
Crit Rev Immunol; 2023; 43(4):11-13. PubMed ID: 37830190
[TBL] [Abstract][Full Text] [Related]
39. Hypertension Management in Peripheral Artery Disease: A Mini Review.
Kharawala A; Nagraj S; Pargaonkar S; Seo J; Kokkinidis DG; Altin SE
Curr Hypertens Rev; 2024; 20(1):1-9. PubMed ID: 38083897
[TBL] [Abstract][Full Text] [Related]
40. Prediction and prevention of ACE-inhibitor-induced angioedema-an unmet clinical need in management of hypertension.
Rubin S; Tomaszewski M
Hypertens Res; 2024 Feb; 47(2):257-260. PubMed ID: 37945891
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
